The Department of Justice (DOJ) and HHS issued a joint letter to state Medicaid administrators urging them to act in accordance with the Americans with Disabilities Act (ADA) and allow access to life-saving hepatitis C medications to people who have both hepatitis C and substance use disorder.
Source: Drug Industry Daily